Discussion on the new price of dacomitinib/dacomitinib after it is included in medical insurance in 2024

Dacomitinib/Dacomitinib (Dacomitinib) is a powerful treatment drug for advanced or metastatic non-small cell lung cancer (NSCLC). It is particularly suitable for patients with specific gene mutations in the epidermal growth factor receptor (EGFR), especially those with exon 19 deletions or exon 21 L858R substitution mutations. As a tyrosine kinase inhibitor, dacomitinib effectively slows down the uncontrolled growth of cancer cells by inhibiting the overactivity of EGFR.

In multiple clinical studies, dacomitinib has demonstrated superior efficacy than gefitinib, significantly extending the progression-free survival of patients. This outstanding performance has attracted much attention in the pharmaceutical industry. Dacomitinib is an effective antineoplastic drug used to treat non-small cell lung cancer. However, patients should be aware of side effects during use and work closely with their doctor to ensure safe and effective treatment.

What is gratifying is that dacomitinib has passed the strict approval of the National Medical Products Administration and has been officially launched in China. More importantly, it has also been successfully included in the national Class B medical insurance drug list. At present, the specifications of dacomitinib commonly sold in the domestic market are 15mg*30 tablets/box, and the original price is about more than 1,000 yuan.

However, forpatients with locally advanced or metastatic NSCLC with specific EGFR gene mutations, they now have the opportunity to reduce their financial burden through medical insurance. Of course, since medical insurance policies and reimbursement ratios vary from region to region, the actual fees paid by patients may vary. In order to obtain the most accurate information, it is recommended that patients directly consult their hospital or local medical insurance bureau. In this way, you can not only understand the specific reimbursement policies and ratios, but also ensure that you enjoy the medical protection you deserve.